BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7874191)

  • 21. Balancing safety and efficacy focus on endometrial protection.
    Boroditsky RS
    J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endometrium--from estrogens alone to TSECs.
    Pickar JH
    Climacteric; 2009 Dec; 12(6):463-77. PubMed ID: 19905899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new hormone therapy problem: do we solve it with long-cycle progesterone therapy?
    Ravnikar V
    Menopause; 2005; 12(6):664-7. PubMed ID: 16278608
    [No Abstract]   [Full Text] [Related]  

  • 27. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy.
    Gompel A
    Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone and endometrial cancer.
    Gompel A
    Best Pract Res Clin Obstet Gynaecol; 2020 Nov; 69():95-107. PubMed ID: 32732107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial safety and bleeding with HRT: what's new?
    Sturdee DW
    Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estrogens, progestins and cancer of the endometrium].
    Laffargue F; Daures JP
    Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hormones in the etiology and prevention of endometrial cancer.
    Gambrell RD
    Clin Obstet Gynaecol; 1986 Dec; 13(4):695-723. PubMed ID: 3791826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone replacement therapy: endometrial and breast effects.
    Yeh IT
    Adv Anat Pathol; 2007 Jan; 14(1):17-24. PubMed ID: 17198307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE; Thorneycroft IH
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
    Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormone substitution therapy in menopause and risk of breast cancer].
    Colin C
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.